A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
about
Iron therapy in anaemic adults without chronic kidney diseaseThe role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal diseaseSafety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trialsSafety of intravenous iron formulations: facts and folkloreEfficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled TrialsFerric Carboxymaltose as Treatment in Women with Iron-Deficiency AnemiaPerioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyOptimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic ReviewIntravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations.Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia RiskPerioperative Hemoglobin Trajectory in Adult Cardiac Surgical Patients.Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.Management of Iron Deficiency Anemia.Ferric carboxymaltose.Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemiaIron deficiency in the elderly population, revisited in the hepcidin era.Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice.Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.Double bull's eye for post-operative intravenous iron in patient blood management: better outcome and cost-effective.Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials.Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.Comparative safety of intravenous ferumoxytol vs ferric carboxymaltose in iron deficiency anemia: A randomized trial.Risk Assessment.
P2860
Q24187098-CD2808B4-8AEE-4B66-AAED-AD83C0F92907Q26771882-B6C5BBE6-6AFC-4C77-997A-313250D2C89FQ26829377-7B91FCA6-6417-4D04-8288-8D69FE94898DQ26853397-96DA04BD-E187-4F31-983B-506B834D60CCQ28085514-1ED1BC4D-43DA-4C61-B902-797D974B6D80Q33607976-8FD068B7-4F5C-415C-8BB1-203F40E8383BQ33818396-92210F7F-DCD1-47B9-A45F-0787199DF92CQ34477467-F51B2DAA-A003-49DE-B469-E56631204E05Q34700903-BA2AEFE9-BA73-493C-A848-F213B2BB184EQ35659768-A83BD9FD-6305-4C1D-9728-7DE1376A2DC1Q35898038-EF2DE1E3-756C-43ED-B413-D8E9480E1745Q36209885-2ABFA087-F9E3-400B-9DA5-7C35256D8B6AQ36243748-F26C13A4-2F59-4CEE-9401-DF5B1BF458BCQ36515685-D33D2DAA-E4BB-4D56-95F9-CD76E2FCFDCFQ36812538-D6447AEB-D98C-4E17-A102-8D307A8D1B51Q37460956-FD9FEB86-10FB-4904-B12A-2F38AB8BADA9Q37629734-93A15727-EA18-4F7A-9A71-A0A77D8DAD98Q37734983-844D66FB-857C-462A-9049-97F9818DA4ACQ38652536-C29CDB1D-25B7-40DB-8A08-5D9DE5DC7F8EQ42370571-99BEF3FC-2A58-498A-8154-0F65973E7AA3Q42508146-9327FC5B-74A6-43B0-8E40-3BAEEEC68159Q43109015-976BE56B-DA08-44A5-8F7A-18976CB10711Q48225857-20122C9D-D03A-4FF3-8E2E-70FEEAEEC40EQ50125158-357ECBF1-4D3B-498A-969B-E4DF6306AF25Q52359774-7817A582-245E-4732-B897-65266577E86F
P2860
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A multicenter, randomized, act ...... s with iron deficiency anemia.
@en
type
label
A multicenter, randomized, act ...... s with iron deficiency anemia.
@en
prefLabel
A multicenter, randomized, act ...... s with iron deficiency anemia.
@en
P2093
P2860
P356
P1433
P1476
A multicenter, randomized, act ...... s with iron deficiency anemia.
@en
P2093
Angelia Butcher
Birbal S Bhaskar
Bruce Akright
Charles Barish
David B Bregman
David Morris
Gioi N Smith-Nguyen
Jane E Onken
Lawrence T Goodnough
P2860
P304
P356
10.1111/TRF.12289
P577
2013-06-17T00:00:00Z